Abstract
Wolfram syndrome also known as DIDMOAD (Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy, and Deafness) is a rare neurodegenerative autosomal recessive disorder. There is evidence of variable expressivity both in patients and heterozygous carriers. In this study, we describe three Persian Wolfram syndrome families with differences in the age of onset, signs and symptoms of the disease. We clinically evaluated affected families for verifying WS clinical diagnosis. After linkage analysis via 5 STR markers, molecular analysis for WFS1 was performed by direct sequencing for patients and available family members. Three homozygous mutations were identified including c.1885 C>T, c.2205C>A both in exon 8 and c.460+1G>A in intron 4. The mutation c.2205C>A was found to be novel. We report interesting phenotype-genotype correlations: homozygous c.1885C>T and c.2205C>A variants were correlated with quite different disease severity and onset in the siblings. We report a rare case of WS with homozygous c.1885C>T who is married and has a healthy child. c.460+1G>A showed a possible partial dominant inheritance put forth by a heterozygous parent showing partial WS symptoms while her daughter displayed typical WS symptoms. Due to variable expressivity, detailed clinical examination and molecular diagnostics should be used to confirm WS and a more exact recurrence risk data.
Similar content being viewed by others
References
Aloi C, Salina A, Pasquali L, Lugani F, Perri K, Russo C, Tallone R, Ghiggeri GM, Lorini R, d’Annunzio G (2012) Wolfram syndrome: new mutations, different phenotype. PLoS One 7(1):e29150
Rigoli L, Di Bella C (2012) Wolfram syndrome 1 and Wolfram syndrome 2. Curr Opin Pediatr 24:512–517
Inoue H, Tanizawa Y, Wasson J, Behn P, Kalidas K, Bernal-Mizrachi E, Mueckler M, Marshall H, Donis-Keller H, Crock P, Rogers D, Mikuni M, Kumashiro H, Higashi K, Sobue G, Oka Y, Permutt MA (1998) A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet 20:143–148
Strom TM, Hortnagel K, Hofmann S, Gekeler F, Scharfe C, Rabl W, Gerbitz KD, Meitinger T (1998) Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum Mol Genet 7:2021–2028
Hofmann S, Philbrook C, Gerbitz K-D, Bauer MF (2003) Wolfram syndrome: structural and functional analyses of mutant and wild-type wolframin, the WFS1 gene product. Hum Mol Genet 12:2003–2012
Kadayifci A, Kepekci Y, Coskun Y, Huang Y (2001) Wolfram syndrome in a family with variable expression. Acta Medica (Hradec Kralove) 44:115–118
Baz P, Azar ST, Medlej R, Bejjani R, Halabi G, Salti I (1999) Role of early fundoscopy for diagnosis of Wolfram syndrome in type 1 diabetic patients. Diabetes Care 22:1376–1378
Ohata T, Koizumi A, Kayo T, Shoji Y, Watanabe A, Monoh K, Higashi K, Ito S, Ogawa O, Wada Y, Takada G (1998) Evidence of an increased risk of hearing loss in heterozygous carriers in a Wolfram syndrome family. Hum Genet 103(4):470–474
Swift M, Swift RG (2000) Psychiatric disorders and mutations at the Wolfram syndrome locus. Biol Psychiatry 47:787–793
Swift RG, Perkins DO, Chase CL, Sadler DB, Swift M (1991) Psychiatric disorders in 36 families with Wolfram syndrome. Am J Psychiatry 148:775–779
Titah SMC, Meunier I, Blanchet C, Lopez S, Rondouin G, Lenaers G, Amati-Bonneau P, Reynier P, Paquis-Flucklinger V, Hamel CP (2012) Cataract as a phenotypic marker for a mutation in WFS1, the Wolfram syndrome gene. Eur J Ophthalmol 22:254–258
Mets RB, Emery SB, Lesperance MM, Mets MB (2010) Congenital cataracts in two siblings with Wolfram syndrome. Ophthalmic Genet 31:227–229
Al-Till M, Jarrah NS, Ajlouni KM (2002) Ophthalmologic findings in fifteen patients with Wolfram syndrome. Eur J Ophthalmol 12:84–88
Milea D, Amati-Bonneau P, Reynier P, Bonneau D (2010) Genetically determined optic neuropathies. Curr Opin Neurol 23:24–28
Kumar S (2010) Wolfram syndrome: important implications for pediatricians and pediatric endocrinologists. Pediatr Diabetes 11:28–37
de Heredia ML, Cleries R, Nunes V (2013) Genotypic classification of patients with Wolfram syndrome: insights into the natural history of the disease and correlation with phenotype. Genet Med 15(7):497–506
Sobhani M, Tabatabaiefar MA, Rajab A, Kajbafzadeh AM, Noori-Daloii MR (2013) Molecular characterization of WFS1 in an Iranian family with Wolfram syndrome reveals a novel frameshift mutation associated with early symptoms. Gene 528(2):309–313
Brogna S, Wen J (2009) Nonsense-mediated mRNA decay (NMD) mechanisms. Nat Struct Mol Biol 16:107–113
Hofmann S, Bauer MF (2006) Wolfram syndrome-associated mutations lead to instability and proteasomal degradation of wolframin. FEBS Lett 580:4000–4004
Guo X, Shen S, Song S, He S, Cui Y, Xing G, Wang J, Yin Y, Fan L, He F, Zhang L (2011) The E3 ligase Smurf1 regulates Wolfram syndrome protein stability at the endoplasmic reticulum. J Biol Chem 286:18037–18047
Hardy C, Khanim F, Torres R, Scott-Brown M, Seller A, Poulton J, Collier D, Kirk J, Polymeropoulos M, Latif F, Barrett T (1999) Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1. Am J Hum Genet 65:1279–1290
Giuliano F, Bannwarth S, Monnot S, Cano A, Chabrol B, Vialettes B, Delobel B, Paquis-Flucklinger V (2005) Wolfram syndrome in French population: characterization of novel mutations and polymorphisms in the WFS1 gene. Hum Mutat 25:99–9100
Domenech E, Gomez-Zaera M, Nunes V (2006) Wolfram/DIDMOAD syndrome, a heterogenic and molecularly complex neurodegenerative disease. Pediatr Endocrinol Rev 3:249–257
van ven Ouweland JMW, Cryns K, Pennings RJE, Walraven I, Janssen GMC, Maassen JA, Veldhuijzen BFE, Arntzenius AB, Lindhout D, Cremers CWRJ, Van Camp G, Dikkeschei LD (2003) Molecular characterization of WFS1 in patients with Wolfram syndrome. J Mol Diagn 5:88–95
Bonnycastle LL, Chines PS, Hara T, Huyghe JR, Swift AJ, Heikinheimo P, Mahadevan J, Peltonen S, Huopio H, Nuutila P, Narisu N, Goldfeder RL, Stitzel ML, Lu S, Boehnke M, Urano F, Collins FS, Laakso M (2013) Autosomal dominant diabetes arising from a Wolfram syndrome 1 mutation. Diabetes 62(11):3943–3950
Rendtorff ND, Lodahl M, Boulahbel H, Johansen IR, Pandya A, Welch KO, Norris VW, Arnos KS, Bitner-Glindzicz M, Emery SB, Mets MB, Fagerheim T, Eriksson K, Hansen L, Bruhn H, Moller C, Lindholm S, Ensgaard S, Lesperance MM, Tranebjaerg L (2011) Identification of p. A684 V missense mutation in the WFS1 gene as a frequent cause of autosomal dominant optic atrophy and hearing impairment. Am J Med Genet A 155A:1298–1313
Acknowledgments
This study was supported by a grant (No. 10818) from Tehran University of Medical Sciences.
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sobhani, M., Tabatabaiefar, M.A., Rajab, A. et al. Significant expressivity of Wolfram syndrome: phenotypic assessment of two known and one novel mutation in the WFS1 gene in three Iranian families. Mol Biol Rep 41, 7499–7505 (2014). https://doi.org/10.1007/s11033-014-3642-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-014-3642-3